Dr. Cheryl Pegus, former Walmart EVP of Health & Wellness, Joins Morgan Health
21 Novembro 2022 - 9:00AM
Business Wire
Dr. Cheryl Pegus, a nationally-recognized leader for her work to
deliver affordable, high-quality care to millions of Americans,
will join Morgan Health to support the organization’s strategic
investments and broader efforts to improve the quality,
affordability and equity of health care.
Dr. Pegus joins Morgan Health from Walmart where she served as
Executive Vice President for Health & Wellness. In her role,
Dr. Pegus established Walmart as a formidable force in health care
innovation and transformation. During her tenure, she launched
notable consumer health programs designed to raise the standard of
care for millions of Americans, including the roll-out of ReliOn
insulin, which has saved customers more than $15 million on the
cost of their insulin. She played a foundational role in broadening
access to critical telehealth services across Walmart’s communities
and worked to expand the footprint of Walmart’s retail Health
Centers across major markets. She also oversaw the company’s
pandemic response with the Health & Wellness team administering
COVID vaccines to tens of millions of customers and associates.
Dr. Pegus will work closely with Dan Hartman and Jeff Ries, who
lead Morgan Health’s ventures and investment efforts. As part of
its mission to improve employer-sponsored health care, Morgan
Health is investing $250 million of JPMorgan Chase & Co.
capital to help scale promising companies focused on driving
greater accountability in health care. To date, Morgan Health has
deployed $105mm in four early-stage companies: Vera Whole Health,
Embold Health, Centivo and LetsGetChecked.
Building on Morgan Health’s accountable care strategy, Dr. Pegus
will help inform the team’s renewed focus on population-based
health initiatives, including investing in and scaling promising
new care delivery models designed to improve health outcomes,
particularly among diverse populations. In addition, she will help
Morgan Health advance its work and strategic investments dedicated
to addressing gaps in mental and behavioral health, diabetes, heart
disease and other chronic conditions among enrollees.
“Cheryl is one of the most respected leaders in health care and
brings clinical and health care business expertise that will help
accelerate the next phase of Morgan Health’s strategy around
population health,” Dan Mendelson, CEO of Morgan Health, said. “She
is also a cardiologist and health equity expert and will play a
critical role in our work to invest in and scale companies that are
making a meaningful difference in reversing the trend of chronic
disease, particularly diabetes and heart disease, across the
commercial market. She recognizes the opportunity that we have to
improve health outcomes for our employees and the more than 150
million Americans who depend on employer-sponsored insurance.”
“Health care innovation continues to be very much needed, and I
am excited to support this incredible Morgan Health team in
accelerating offerings that improve outcomes,” Dr. Pegus said.
“Moving new science into practice, supporting consumers in
understanding what’s available and needed to stay healthy, while
assisting health care professionals in doing our best work can
deliver on the Quadruple Aim.”
Dr. Pegus brings more than 20 years of experience across the
health sector to support Morgan Health’s vision and mission. Prior
to joining Walmart, Dr. Pegus served as President of Consumer
Solutions and Chief Medical Officer for Cambia Health Solutions.
She also served as the first chief medical officer at Walgreens and
as General Manager and Chief Medical Officer for SymCare
Personalized Health Solutions, a diabetes-focused division of
Johnson & Johnson. Dr. Pegus also had roles at Pfizer, where
she focused on the development of clinical protocols and early
disease management programs, and Aetna, where her work supported a
focus on wellness, women's health, health equity initiatives and
predictive analytics. She began her career in private practice as a
cardiologist and previously served as board chair for the
Association of Black Cardiologists.
In addition to her role at Morgan Health, Dr. Pegus will
continue to serve as a senior advisor to Walmart and will be
joining Atria. Dr. Pegus is co-founder of A New Beat and has served
on the board of the American Heart Association as well as public
and private companies.
About JPMorgan Chase J.P. Morgan is a global leader in
financial services, offering solutions to the world's most
important corporations, governments and institutions in more than
100 countries. We also lead volunteer service activities for
employees in local communities by utilizing our many resources,
including those that stem from access to capital, economies of
scale, global reach and expertise.
About Morgan Health Morgan Health is a JPMorgan Chase
business unit focused on improving employer-sponsored health care.
Through its investments and the advancement of accountable care,
Morgan Health is working to improve the quality, equity and
affordability of employer-sponsored health care for JPMorgan Chase
employees, their families and the U.S. health system. The business
is led by Dan Mendelson, CEO of Morgan Health, reporting to Peter
Scher, Vice Chairman of JPMorgan Chase & Co. and a member of
the firm’s Operating Committee. Morgan Health is headquartered in
Washington, D.C. Visit www.morganhealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221121005299/en/
Media Contacts: Clare Krusing clare.krusing@jpmchase.com
JP Morgan Chase (NYSE:JPM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
JP Morgan Chase (NYSE:JPM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024